Related Experiment Video
Updated: Mar 11, 2026
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Gene Therapy for Post-infarction Ventricular Tachycardia
1Division of Cardiovascular Medicine, University of Massachusetts Medical School, 55 Lake Avenue, North, Worcester, MA, 01655, USA. donahuelab@gmail.com.
Insights
Researchers developed a new animal model and gene delivery method to study and treat ventricular tachyarrhythmias, a major cause of sudden cardiac death. This preclinical model holds promise for future gene therapies in clinical practice.
Area of Science:
- Cardiovascular Research
- Gene Therapy
- Animal Models
Background:
- Cardiac arrhythmias, particularly ventricular tachyarrhythmias, are a primary cause of sudden cardiac death.
- Myocardial infarction scars are frequently associated with fatal arrhythmias.
Purpose of the Study:
- To establish a reproducible animal model for inducible ventricular tachyarrhythmias post-myocardial infarction.
- To develop and validate a gene delivery method for targeting myocardial scar tissue.
Main Methods:
- Creation of a myocardial infarction scar in an animal model.
- Development of a gene delivery system for scar and surrounding myocardial tissues.
- Induction of ventricular tachyarrhythmias in the established model.
Main Results:
- The animal model reproducibly exhibits inducible ventricular tachyarrhythmias after myocardial infarction healing.
- The gene delivery method successfully targets scar and adjacent myocardial tissues.
Conclusions:
- This preclinical model and gene delivery system are valuable tools for investigating ventricular tachyarrhythmia mechanisms.
- The approach facilitates efficacy testing of novel gene therapies for arrhythmias.
- Potential for future translation to clinical applications in treating sudden cardiac death.
Abstract:
Cardiac arrhythmias are a leading cause of morbidity and mortality in the developed world. In particular, cardiac arrest or sudden cardiac death is the leading cause of death in these countries. Death generally results from a ventricular tachyarrhythmia, and pathology data have shown that cardiac arrest victims very frequently have evidence of coronary atherosclerosis with either acute ischemia or healed myocardial infarction. In this work, we describe an animal model that reproducibly has inducible ventricular tachyarrhythmias after healing of a myocardial infarction scar and a gene delivery method that allows gene transfer to the scar and surrounding myocardial tissues. Use of the method allows gene delivery to the arrhythmia model for testing of hypotheses related to ventricular tachyarrhythmia mechanisms and for efficacy testing of proposed gene therapies. To date, all work in this area has been preclinical, but it is our hope that continued development in this area will 1 day allow translation of this method into clinical practice.
More Related Videos
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
05:15Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
Published on: July 27, 2022
Related Concept Videos
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
01:14Myocarditis III: Medical Management
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:25Dysrhythmias VI: Management of Dysrhythmias
01:26Heart Failure Drugs: Inotropic Agents
01:29Cardiomyopathy V: Interprofessional Care